Biotech · Private company
Qifeng Zhang
Track this companyFree. Adds Qifeng Zhang to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- BBD-1 Multi target Immune Enhancement Targeting AgentPhase 2 · Allergic Reaction (IgA) VasculitisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Evaluate the Effectiveness and Safety of BBD-1 Multi-target Immune Enhancement Targeting Agent in the Treatment of Hypersensitivity Reaction (IgA) VasculitisPHASE2 · RECRUITING · started Aug 10, 2026ClinicalTrials.gov NCT07595367 · fetched Nov 12, 2026